When Aaron Devanathan, Pharm.D., arrived at the UNC Eshelman School of Pharmacy in 2017, his advisor, Dean Angela Kashuba, asked him to look inward before he got to work. “Think about what your legacy is going to be,” she said. … Read more
Today, an estimated 700,000 people in the United States are living with a primary brain tumor. Members of the Shawn Hingtgen Lab at the UNC Eshelman School of Pharmacy are focused on curing the disease, specifically glioblastoma, one of the … Read more
According to the Centers for Disease Control, the flu vaccine for the 2018-19 season was only 29 percent effective. Kristy Ainslie, Ph.D., wants to improve that number with the help of a $2.8 million grant. “All of us have been … Read more
UNC-Chapel Hill startup and KickStart Venture Services award winner Assure Technologies developed a novel medical device for precise, error-free dose measurement of medications for pediatric patients Story by Shellie Edge, photography, Sarah Daniels, Innovate Carolina The Assure Technologies device can … Read more
An interdisciplinary team from the University of North Carolina at Chapel Hill has received funding to explore the critical role of airway mucus in the transmission, infection and spread versus protection from COVID-19. While the world waits for a vaccine … Read more
By: Drew Stenger and Jon Easter, RPh Long before the COVID-19 pandemic was spreading across the globe, the U.S. was already facing an epidemic in healthcare that was spreading, costly, and ultimately unsustainable relative to healthcare spending. That … Read more
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Qui dicta minus molestiae vel beatae natus eveniet ratione temporibus aperiam harum alias officiis assumenda officia quibusdam deleniti eos cupiditate dolore doloribus! Ad dolore dignissimos asperiores dicta facere optio quod commodi nam … Read more
(Photo courtesy of Stephen Frye) A group of researchers from the University of North Carolina at Chapel Hill are part of a new research proposal to create chemical and biological tools to explore novel molecular targets related to Alzheimer’s disease. … Read more
